Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
Drugs and Biologicals is a federal award for 241-Network Contract Office 01 (36C241) held by Novartis Pharmaceuticals Corp. Estimated value $810K ($810K obligated). Current period of performance ends Mar 14, 2027. Last award drew 1 bidder. Place of performance: WEST HAVEN CT.
Drugs and Biologicals. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Mar 14, 2027 (148 days remaining). Agencies typically plan 12–18 months ahead — at 4.9 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C24125F0148? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNovartis Pharmaceuticals Corp — $23.5M obligated across 59 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24125F0148?
36C24125F0148 (Drugs and biologicals) is a 241-Network Contract Office 01 (36C241) award with a potential value of $810K, currently held by Novartis Pharmaceuticals Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C241-25-F-0148?
36C241-25-F-0148 is the dashed form of PIID 36C24125F0148 (Drugs and biologicals), held by Novartis Pharmaceuticals Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24125F0148?
241-Network Contract Office 01 (36C241) awarded 36C24125F0148 to Novartis Pharmaceuticals Corp (potential $810K).
Who is the incumbent on 36C24125F0148?
Novartis Pharmaceuticals Corp is the incumbent with $23.5M across 59 related awards in SCOUT’s public footprint. The current period of performance ends Mar 14, 2027.
When does Novartis Pharmaceuticals Corp’s 36C24125F0148 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C24125F0148? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.